![](/img/cover-not-exists.png)
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group
Pignata, S, Scambia, G, Pisano, C, Breda, E, Di Maio, M, Greggi, S, Ferrandina, G, Lorusso, D, Zagonel, V, Febbraro, A, Riva, N, De Rosa, V, Gallo, C, Perrone, FVolume:
96
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6603787
Date:
June, 2007
File:
PDF, 86 KB
english, 2007